MarketCap
Facebook
X
TelegramAlexion Pharmaceuticals, Inc. DSO 2011-2025 | ALXN
DSO Jährlich Alexion Pharmaceuticals, Inc.
| 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|
| 84.7 | 90.9 | 81.5 | 74.7 | 76.9 | 74.7 | 70.7 | 99.2 | 95.1 | 114 |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 114 | 70.7 | 86.2 |
DSO anderer Aktien in der Pharmaeinzelhändler
| Name | DSO | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
AbbVie
ABBV
|
267 | $ 223.98 | -0.53 % | $ 396 B |  USA |
 |
Alpine Immune Sciences
ALPN
|
154 | - | - | $ 2.17 B | USA |
 |
Arbutus Biopharma Corporation
ABUS
|
31.5 | $ 4.67 | 1.74 % | $ 775 M |  Canada |
 |
Aclaris Therapeutics
ACRS
|
6.01 | $ 3.36 | 2.75 % | $ 260 M | USA |
 |
Acasti Pharma
ACST
|
1.97 | - | 4.01 % | $ 150 M | Canada |
 |
Adaptimmune Therapeutics plc
ADAP
|
25 | - | -15.15 % | $ 60.3 M |  Britain |
 |
Aeglea BioTherapeutics
AGLE
|
216 | - | - | $ 1.01 B | USA |
 |
Albireo Pharma
ALBO
|
14.7 | - | -0.23 % | $ 916 M | USA |
 |
Ascendis Pharma A/S
ASND
|
132 | $ 210.16 | 4.43 % | $ 5 B |  Danmark |
 |
Ayala Pharmaceuticals
AYLA
|
61.7 | - | - | $ 7.46 M |  Israel |
 |
Aptorum Group Limited
APM
|
20.6 | $ 1.33 | -1.48 % | $ 7.25 M |  China |
 |
Alterity Therapeutics Limited
ATHE
|
16.2 K | $ 3.42 | 2.09 % | $ 8.23 B |  Australia |
 |
EyeGate Pharmaceuticals, Inc.
EYEG
|
2.75 K | - | -1.52 % | $ 24.7 M | USA |
 |
Amphastar Pharmaceuticals
AMPH
|
62.6 | $ 25.9 | 0.74 % | $ 1.25 B | USA |
 |
Anika Therapeutics
ANIK
|
77.3 | $ 9.49 | - | $ 139 M | USA |
 |
Brickell Biotech
BBI
|
254 | - | -5.38 % | $ 6.06 M | USA |
 |
BeiGene, Ltd.
BGNE
|
49.5 | - | 0.49 % | $ 251 B |  Cayman-islands |
 |
Bellicum Pharmaceuticals
BLCM
|
6.09 | - | -9.72 % | $ 5.89 M | USA |
 |
Berkeley Lights
BLI
|
103 | - | -7.31 % | $ 87 M | USA |
 |
Aytu BioScience
AYTU
|
150 | $ 2.28 | - | $ 14.3 M | USA |
 |
Arena Pharmaceuticals
ARNA
|
946 | - | -6.81 % | $ 3.04 B | USA |
 |
Biogen
BIIB
|
57.9 | $ 172.5 | - | $ 25.1 B | USA |
 |
Baudax Bio
BXRX
|
126 | - | 0.59 % | $ 63 K | USA |
 |
Benitec Biopharma
BNTC
|
141 | $ 12.96 | 1.17 % | $ 533 M | USA |
 |
ChromaDex Corporation
CDXC
|
13.2 | - | -0.88 % | $ 598 M | USA |
 |
Axon Enterprise
AXON
|
134 | $ 581.03 | 2.22 % | $ 44 B | USA |
 |
Can-Fite BioPharma Ltd.
CANF
|
28.1 | $ 0.29 | -0.31 % | $ 631 M | Israel |
 |
Checkpoint Therapeutics
CKPT
|
6.83 | - | - | $ 169 M | USA |
 |
Caladrius Biosciences
CLBS
|
164 | - | -16.75 % | $ 25.8 M | USA |
 |
Catalyst Biosciences
CBIO
|
3.24 | $ 15.31 | - | $ 1.01 B | USA |
 |
Clovis Oncology
CLVS
|
65.5 | - | -7.23 % | $ 13 M | USA |
 |
Cerus Corporation
CERS
|
59.2 | $ 2.15 | 13.76 % | $ 397 M | USA |
 |
Celldex Therapeutics
CLDX
|
86.5 | $ 27.94 | - | $ 1.8 M | USA |
 |
Deciphera Pharmaceuticals
DCPH
|
60.8 | - | - | $ 2.18 B | USA |
 |
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
169 | $ 11.44 | 7.92 % | $ 740 M | USA |
 |
Eloxx Pharmaceuticals
ELOX
|
157 | - | -5.68 % | $ 8.28 M | USA |
 |
Epizyme
EPZM
|
47.2 | - | - | $ 249 M | USA |